The first patient has been enrolled in a trial investigating the stand-alone use of the Hydrus microstent in mild to moderate open-angle glaucoma, according to a press release from Ivantis.
The FRONTIER pivotal clinical trial will investigate the effectiveness of the Hydrus microstent in patients who have already had cataract surgery. In the HORIZON pivotal trial, patients who received the microstent and underwent cataract surgery at the same time had a reduction in visual field loss and were less likely to require medications or additional surgeries after 5 years.
“With (Read more...)